CPIXCUMBERLAND PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of CUMBERLAND PHARMACEUTICALS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPIX본 종목 | $104M#3 | — | 6.0x#2 | 2.3x#1 | 17.6%#1 | 56.2%#2 | -6.3%#1 | -16.3%#1 | — | — | — | — |
| PMN | $112M#1 | — | 2.3x#1 | — | — | -1529.3%#5 | — | -80.4%#3 | — | — | 17.1%#1 | — |
| GNLX | $107M#2 | — | 6.6x#4 | 13347.4x#3 | 0.0%#2 | -7.6%#4 | -415175.0%#3 | -199.5%#5 | -424.2%#2 | — | — | — |
| PLYX | $101M#4 | — | 9.3x#5 | — | — | 70.4%#1 | — | -82.1%#4 | — | — | — | — |
| ANIX | $91M#5 | — | 6.3x#3 | 431.2x#2 | 0.0%#2 | 13.0%#3 | -5571.9%#2 | -75.5%#2 | -87.0%#1 | — | -27.2%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice